Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Cm Life Sciences Inc Cl A (CMLF)

Cm Life Sciences Inc Cl A (CMLF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 641,990
  • Shares Outstanding, K 55,344
  • Annual Sales, $ 0 K
  • Annual Income, $ -190 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 128.40
Trade CMLF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility N/A
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.02 +5.26%
on 07/19/21
15.21 -23.73%
on 06/30/21
-0.91 (-7.27%)
since 06/22/21
3-Month
10.20 +13.73%
on 05/11/21
15.21 -23.73%
on 06/30/21
-2.35 (-16.85%)
since 04/22/21

Most Recent Stories

More News
Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company

STAMFORD, Conn., July 22, 2021 (GLOBE NEWSWIRE) -- Sema4 , a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced the completion...

CMLF : 11.60 (-7.05%)
TWST : 52.97 (+7.93%)
MGTA : 1.7700 (+2.31%)
Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors

Sema4 , a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced the appointment of renowned executive Jason Ryan to its Board of...

CMLF : 11.60 (-7.05%)
MGTA : 1.7700 (+2.31%)
RHHBY : 42.0000 (+2.34%)
OMIC : 4.18 (+5.29%)
NVTA : 5.37 (+19.07%)
TWST : 52.97 (+7.93%)
CM Life Sciences and Sema4 Announce Release of Definitive Proxy Statement for July 21 Shareholder Meeting to Vote on Business Combination

CM Life Sciences (Nasdaq: CMLF), a special purpose acquisition company, or SPAC, sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP, has filed its definitive proxy statement with the...

CMLF : 11.60 (-7.05%)
Sema4 Appoints Andrew Kasarskis, Health Data Expert and Precision Medicine Scientist, as Chief Data Officer

Sema4 , a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced the appointment of Andrew Kasarskis , PhD, to the newly established...

CMLF : 11.60 (-7.05%)
Sema4 and CM Life Sciences Announce the Filing of Amended Preliminary Proxy Statement

Sema4 , a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, and CM Life Sciences (Nasdaq: CMLF), a special purpose acquisition company, or...

CMLF : 11.60 (-7.05%)
AdventHealth and Sema4 Launch a Data-driven Precision Medicine Program to Optimize Patient Care and Outcomes

AdventHealth and Sema4 , a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced a wide-ranging collaboration that builds upon...

CMLF : 11.60 (-7.05%)
Sema4 to Participate in Upcoming Investor Conferences

Sema4 , a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced that members of the Sema4 management team will participate in fireside...

CMLF : 11.60 (-7.05%)
Sema4 and CM Life Sciences Announce the Filing of the Schedule-14A Proxy Statement in Connection with the Proposed Merger

Sema4 , a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, and CM Life Sciences (Nasdaq: CMLF), a special purpose acquisition company, or...

CMLF : 11.60 (-7.05%)
CM Life Sciences Announces Filing of Amended Annual Report on Form 10-K Relating to Restatement of Financial Statements in Accordance with Recent SEC Guidance

CM Life Sciences, Inc. (NASDAQ:CMLF) today announced that it has filed with the Securities and Exchange Commission (SEC) an amended annual report on Form 10-K/A and a Form 8-K reporting the restatement...

CMLF : 11.60 (-7.05%)
NorthShore and Sema4 Launch System-Wide Genomics Program to Improve Primary and Specialty Care with Data-Driven Insights

NorthShore University HealthSystem (NorthShore) and Sema4 , a patient-centered health intelligence company, today announced the availability of a system-wide data-driven genomics program that utilizes...

CMLF : 11.60 (-7.05%)

Business Summary

CM Life Sciences Inc. is a blank check company. It formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. CM Life Sciences Inc. is based in New York.

See More

Key Turning Points

3rd Resistance Point 13.25
2nd Resistance Point 12.84
1st Resistance Point 12.22
Last Price 11.60
1st Support Level 11.19
2nd Support Level 10.78
3rd Support Level 10.16

See More

52-Week High 27.18
Fibonacci 61.8% 20.49
Fibonacci 50% 18.42
Fibonacci 38.2% 16.35
Last Price 11.60
52-Week Low 9.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar